Maribel Parra

2.7k total citations
34 papers, 2.1k citations indexed

About

Maribel Parra is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Maribel Parra has authored 34 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Maribel Parra's work include Epigenetics and DNA Methylation (11 papers), Histone Deacetylase Inhibitors Research (10 papers) and Signaling Pathways in Disease (6 papers). Maribel Parra is often cited by papers focused on Epigenetics and DNA Methylation (11 papers), Histone Deacetylase Inhibitors Research (10 papers) and Signaling Pathways in Disease (6 papers). Maribel Parra collaborates with scholars based in Spain, United States and Netherlands. Maribel Parra's co-authors include Bruna Barneda‐Zahonero, Eric Verdin, Tokameh Mahmoudi, Eric N. Olson, Pura Muñoz‐Cánoves, Shusheng Wang, Xiu-Min Li, Rhonda Bassel‐Duby, Haleh Rafati and Frederic Lluı́s and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Maribel Parra

34 papers receiving 2.1k citations

Peers

Maribel Parra
Kovalev Gi United States
Jerry DiSalvo United States
Robert Signer United States
Edward J. Unsworth United States
Kovalev Gi United States
Maribel Parra
Citations per year, relative to Maribel Parra Maribel Parra (= 1×) peers Kovalev Gi

Countries citing papers authored by Maribel Parra

Since Specialization
Citations

This map shows the geographic impact of Maribel Parra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maribel Parra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maribel Parra more than expected).

Fields of papers citing papers by Maribel Parra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maribel Parra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maribel Parra. The network helps show where Maribel Parra may publish in the future.

Co-authorship network of co-authors of Maribel Parra

This figure shows the co-authorship network connecting the top 25 collaborators of Maribel Parra. A scholar is included among the top collaborators of Maribel Parra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maribel Parra. Maribel Parra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrios, Oriol de, María Vila-Casadesús, Thomas Graf, et al.. (2022). The HDAC7–TET2 epigenetic axis is essential during early B lymphocyte development. Nucleic Acids Research. 50(15). 8471–8490. 5 indexed citations
2.
Vilarrasa‐Blasi, Roser, Núria Verdaguer-Dot, Laura Belver, et al.. (2021). Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma. Leukemia. 36(2). 583–587. 6 indexed citations
3.
Barrios, Oriol de, Juan L. Trincado, Antonio Agraz-Doblás, et al.. (2020). HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia. Leukemia. 35(7). 2086–2091. 9 indexed citations
4.
Parra, Maribel, Maria João Baptista, Eulàlia Genescà, Pere Llinàs‐Arias, & Manel Esteller. (2020). Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute. Hematological Oncology. 38(4). 432–438. 7 indexed citations
5.
Ramiro, Almudena R., et al.. (2019). From Loops to Looks: Transcription Factors and Chromatin Organization Shaping Terminal B Cell Differentiation. Trends in Immunology. 41(1). 46–60. 21 indexed citations
6.
Rodríguez‐Ubreva, Javier, Virginia G. de Yébenes, Bruna Barneda‐Zahonero, et al.. (2016). In vivo conditional deletion of HDAC7 reveals its requirement to establish proper B lymphocyte identity and development. The Journal of Experimental Medicine. 213(12). 2591–2601. 37 indexed citations
7.
Barneda‐Zahonero, Bruna, Jordi Serra-Musach, Abul Bashar Mir Md. Khademul Islam, et al.. (2015). The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma. Cell Death and Disease. 6(2). e1635–e1635. 43 indexed citations
8.
Barneda‐Zahonero, Bruna, Haleh Rafati, Abul Bashar Mir Md. Khademul Islam, et al.. (2013). HDAC7 Is a Repressor of Myeloid Genes Whose Downregulation Is Required for Transdifferentiation of Pre-B Cells into Macrophages. PLoS Genetics. 9(5). e1003503–e1003503. 52 indexed citations
9.
Barneda‐Zahonero, Bruna & Maribel Parra. (2012). Histone deacetylases and cancer. Molecular Oncology. 6(6). 579–589. 370 indexed citations
10.
Rafati, Haleh, Maribel Parra, Shweta Hakre, et al.. (2011). Repressive LTR Nucleosome Positioning by the BAF Complex Is Required for HIV Latency. PLoS Biology. 9(11). e1001206–e1001206. 144 indexed citations
11.
Rodríguez‐Ubreva, Javier, Laura Ciudad, David Gómez-Cabrero, et al.. (2011). Pre-B cell to macrophage transdifferentiation without significant promoter DNA methylation changes. Nucleic Acids Research. 40(5). 1954–1968. 30 indexed citations
12.
Parra, Maribel & Eric Verdin. (2010). Regulatory signal transduction pathways for class IIa histone deacetylases. Current Opinion in Pharmacology. 10(4). 454–460. 112 indexed citations
13.
Schubert, Alexis, Thien‐Phong Vu Manh, Luísa de Andrés-Aguayo, et al.. (2009). A Robust and Highly Efficient Immune Cell Reprogramming System. Cell stem cell. 5(5). 554–566. 118 indexed citations
14.
Parra, Maribel. (2009). Epigenetic events during B lymphocyte development. Epigenetics. 4(7). 462–468. 30 indexed citations
15.
Parra, Maribel, Tokameh Mahmoudi, & Eric Verdin. (2007). Myosin phosphatase dephosphorylates HDAC7, controls its nucleocytoplasmic shuttling, and inhibits apoptosis in thymocytes. Genes & Development. 21(6). 638–643. 71 indexed citations
16.
Mahmoudi, Tokameh, Maribel Parra, Robert G.J. Vries, et al.. (2006). The SWI/SNF Chromatin-remodeling Complex Is a Cofactor for Tat Transactivation of the HIV Promoter. Journal of Biological Chemistry. 281(29). 19960–19968. 146 indexed citations
17.
Jardı́, Mercè, Shinichi Saito, Ettore Appella, et al.. (2005). The alkylating carcinogen N-methyl-N’-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases. Thrombosis and Haemostasis. 93(3). 584–591. 8 indexed citations
18.
Parra, Maribel, Herbert G. Kasler, Timothy A. McKinsey, Eric N. Olson, & Eric Verdin. (2004). Protein Kinase D1 Phosphorylates HDAC7 and Induces Its Nuclear Export after T-cell Receptor Activation. Journal of Biological Chemistry. 280(14). 13762–13770. 117 indexed citations
19.
Parra, Maribel, Mercè Jardı́, Magdalena Koziczak, Yoshikuni Nagamine, & Pura Muñoz‐Cánoves. (2001). p53 Phosphorylation at Serine 15 Is Required for Transcriptional Induction of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene by the Alkylating AgentN-Methyl-N′-nitro-N-nitrosoguanidine. Journal of Biological Chemistry. 276(39). 36303–36310. 24 indexed citations
20.
Lluı́s, Frederic, Josep Roma, Mònica Suelves, et al.. (2001). Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood. 97(6). 1703–1711. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026